AMANDA KELSEY JEDRZEJAK: Open Payments
NPI 1376218859 · CHICAGO RIDGE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,077 in 132 payments from 43 companies in 2025. Trend: 2023 $2,007 · 2024 $1,931 · 2025 $3,077
Food & beverage: $2,794Education: $283
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $286 |
| Lilly USA, LLC | 7 | $237 |
| ABBVIE INC. | 12 | $212 |
| PFIZER INC. | 7 | $143 |
| AstraZeneca Pharmaceuticals LP | 7 | $141 |
| GlaxoSmithKline, LLC. | 5 | $138 |
| Exelixis Inc. | 2 | $126 |
| EMD Serono, Inc. | 5 | $116 |
| Merck Sharp & Dohme LLC | 4 | $104 |
| Incyte Corporation | 5 | $102 |
Products named: VERZENIO, VENCLEXTA, JEMPERLI, KISQALI, Lenvima, REBLOZYL, ZEPZELCA, Nubeqa.
Industry payments across IL — which companies pay providers there.
